Author: Herrera-Lasso Regás, Valeria; Dordal Culla, MarÃa Teresa; Lleonart Bellfill, Ramón
Title: Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection() Cord-id: gn6v9dr5 Document date: 2020_11_27
ID: gn6v9dr5
Snippet: Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infec
Document: Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions. Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included; an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over. Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included.
Search related documents:
Co phrase search for related documents- abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- abdominal pain and adr adverse drug reaction: 1
- abdominal pain and adrenal cortex: 1
- abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
- abdominal pain and lopinavir ritonavir combination: 1
- abdominal pain and maculopapular rash: 1, 2, 3, 4, 5
- aberrant response and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- aberrant response and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- aberrant response and liver damage: 1
- aberrant response and lung inflammatory response: 1
- activation inhibit and acute respiratory distress syndrome: 1, 2
- activation inhibit and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation inhibit and lopinavir ritonavir: 1
- activation inhibit and lung inflammatory response: 1, 2
- activity show and acute respiratory distress syndrome: 1, 2, 3
- activity show and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- activity show and liver damage: 1
Co phrase search for related documents, hyperlinks ordered by date